Details

NameSymbolSector
TORRENT PHARMACEUTICALS LTD.TORNTPHARMPharmaceuticals
Open
4600
High
4600
Low
4497.5
Close
4504
Volume
573684
Exchange
nse
Time
15-Jun-2026

Outlook

Score:

1

Rating:

RISKY

Candlestick Pattern

CandlepatternofTorrentPharmaceuticalsis
Marubozu
EstimatedStoplossofTorrentPharmaceuticalsis
4600
TorrentPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
Marubozu
candlepatternindicatesTorrentPharmaceuticalshaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

TorrentPharmaceuticalsisin
Sideways trendℹ
.
PriceofTorrentPharmaceuticalsis
Upℹ
by

3.52

%.
Target
Buy@

4004.3

Sell@

4591.98

Current@

4504

Volume

ThetradevolumeofTorrentPharmaceuticalshasbeen
Goodℹ
ThoughthevolumetrendforTorrentPharmaceuticalsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofTorrentPharmaceuticalsis

Up

by

33.73

%

Valuation

ThecurrentmarketpriceofTorrentPharmaceuticalsis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth14989crandtotalassetsworth14989cr,thebalancesheetofTorrentPharmaceuticalsis:
Balancedℹ
.
Cashflow
TorrentPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 261cr

.Itis
Downℹ
by

180.06

%.
47.61% i.e. ₹ 2585cr earned in operatingℹ
9.94% i.e. ₹ 540cr spent in investingℹ
42.3% i.e. ₹ 2297cr spent in financingℹ
0.15% i.e. ₹ 8cr spent in otherℹ
TorrentPharmaceuticalshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 326cr

.Itis
Upℹ
by

196.36

%.
52.51% i.e. ₹ 3266cr earned in operatingℹ
2.68% i.e. ₹ 167cr spent in investingℹ
44.68% i.e. ₹ 2779cr spent in financingℹ
0.13% i.e. ₹ 8cr earned in otherℹ
Income
TheincomeofTorrentPharmaceuticalsis

₹ 3275cr

and

Profit

is:

₹ 591cr

TorrentPharmaceuticalsProfitisupby:

7.85

%andIncomeisUpby:

4.27

%
TheincomeofTorrentPharmaceuticalsis

₹ 3141cr

and

Profit

is:

₹ 548cr

TorrentPharmaceuticalsProfitisupby:

10.04

%andIncomeisUpby:

6.8

%
TheincomeofTorrentPharmaceuticalsis

₹ 2941cr

and

Profit

is:

₹ 498cr

TorrentPharmaceuticalsProfitisdownby:

0.99

%andIncomeisUpby:

3.48

%
By using this site you agree to the use of cookies to deliver a better site experience.